Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,199 | -68,239 | -50,058 | -32,211 | -16,024 |
| Depreciation Amortization | -1,395 | -166 | 1,419 | 1,533 | 809 |
| Other Working Capital | -1,529 | -4,459 | -4,517 | -2,331 | -1,203 |
| Other Operating Activity | 4,263 | 14,018 | 10,193 | 6,406 | 3,104 |
| Operating Cash Flow | $-20,860 | $-58,846 | $-42,963 | $-26,603 | $-13,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -297 | -1,578 | -1,235 | -632 | -450 |
| Purchase Of Investment | -54,062 | -332,203 | -238,635 | -142,080 | -74,522 |
| Sale Of Investment | 70,750 | 242,389 | 157,139 | 84,689 | 15,439 |
| Investing Cash Flow | $16,391 | $-91,392 | $-82,731 | $-58,023 | $-59,533 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 154 | 127,861 | 127,355 | 127,170 | 48,848 |
| Financing Cash Flow | $154 | $127,861 | $127,355 | $127,170 | $48,848 |
| Exchange Rate Effect | -12 | -49 | -90 | -39 | 25 |
| Beginning Cash Position | 40,456 | 62,882 | 62,882 | 62,882 | 62,882 |
| End Cash Position | 36,129 | 40,456 | 64,453 | 105,387 | 38,908 |
| Net Cash Flow | $-4,327 | $-22,426 | $1,571 | $42,505 | $-23,974 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,860 | -58,846 | -42,963 | -26,603 | -13,314 |
| Capital Expenditure | -297 | -1,578 | -1,235 | -632 | -450 |
| Free Cash Flow | -21,157 | -60,424 | -44,198 | -27,235 | -13,764 |